BioIVT Revenue and Competitors
Estimated Revenue & Valuation
- BioIVT's estimated annual revenue is currently $69.3M per year.
- BioIVT's estimated revenue per employee is $155,000
Employee Data
- BioIVT has 447 Employees.
- BioIVT grew their employee count by 4% last year.
BioIVT's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP - Technology ADME-TOX | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | VP Scientific Consulting | Reveal Email/Phone |
5 | VP Human Resources | Reveal Email/Phone |
6 | VP, Corporate Development | Reveal Email/Phone |
7 | SVP Global Operations | Reveal Email/Phone |
8 | SVP, Global Commercial Operations | Reveal Email/Phone |
9 | VP, FP&A | Reveal Email/Phone |
10 | VP & General Manager, Asterand Bioscience Detroit Operations | Reveal Email/Phone |
BioIVT Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is BioIVT?
BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the world's premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
N/A
Total Funding
447
Number of Employees
$69.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioIVT News
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has...
BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in...
Westbury, New York-based BioIVT, announced on Tuesday, April 5, that it had acquired Memphis-based Tennessee Blood Services (TBS).
Other Companies in Hicksville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $159.6M | 473 | 9% | N/A |
#2 | $88.3M | 487 | -2% | N/A |
#3 | $750M | 620 | N/A | N/A |
#4 | $220.4M | 653 | -11% | N/A |